Home›Trial›NCT07330778
🔬NCT07330778Phase 1RECRUITING

A Study of CDX-622 in Participants With Mild to Moderate Asthma

Study Summary

This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma.

Conditions
Mild to Moderate Asthma
Interventions / Drugs
CDX-622
View on ClinicalTrials.gov ↗
Sponsor
CLDX
Celldex Therapeutics
Immuno-Oncology
C50/100
Study Details
Enrollment12 participants
Primary Completion—
Lead SponsorCelldex Therapeutics
Data Retrieved2026-04-11 04:09:37.490128+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.